Symbols / ACET Stock $8.31 +3.10% Adicet Bio, Inc.

Healthcare • Biotechnology • United States • NCM
ACET (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.

Stock Fundamentals
Scroll to Statements
Market Cap 77.38M Enterprise Value — Income — Sales — Book/sh — Cash/sh —
Dividend Yield — Payout — Employees — IPO — P/E — Forward P/E —
PEG — P/S — P/B — P/C — EV/EBITDA — EV/Sales —
Quick Ratio — Current Ratio — Debt/Eq — LT Debt/Eq — EPS (ttm) -16.95 EPS next Y —
EPS Growth — Revenue Growth — Earnings — ROA — ROE — ROIC —
Gross Margin — Oper. Margin — Profit Margin — Shs Outstand 9.60M Shs Float — Short Float —
Short Ratio — Short Interest — 52W High — 52W Low — Beta — Avg Volume —
Volume — Target Price — Recom — Prev Close $8.06 Price $8.31 Change 3.10%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$53.00
Mean price target
2. Current target
$8.31
Latest analyst target
3. DCF / Fair value
$-101.04
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$8.31
Low
$18.00
High
$128.00
Mean
$53.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-23 main HC Wainwright & Co. Buy → Buy $27
2026-03-13 main Guggenheim Buy → Buy $100
2026-01-21 main HC Wainwright & Co. Buy → Buy $50
2026-01-06 main Canaccord Genuity Buy → Buy $18
2025-11-07 main HC Wainwright & Co. Buy → Buy $9
2025-10-08 main Guggenheim Buy → Buy $8
2025-09-19 reit Guggenheim Buy → Buy $7
2025-03-21 reit Guggenheim Buy → Buy $7
2025-03-07 reit Citizens Capital Markets Market Perform → Market Perform —
2025-03-07 reit HC Wainwright & Co. Neutral → Neutral —
2025-02-27 reit HC Wainwright & Co. Neutral → Neutral —
2025-02-06 reit JMP Securities Market Perform → Market Perform —
2025-02-05 reit HC Wainwright & Co. Neutral → Neutral —
2024-12-19 reit HC Wainwright & Co. Neutral → Neutral —
2024-11-18 reit HC Wainwright & Co. — → Neutral —
2024-08-14 reit HC Wainwright & Co. Buy → Buy $10
2024-08-14 main Canaccord Genuity Buy → Buy $19
2024-07-08 reit HC Wainwright & Co. Buy → Buy $10
2024-06-24 reit HC Wainwright & Co. Buy → Buy $10
2024-06-05 reit HC Wainwright & Co. Buy → Buy $10
News
RSS: Latest ACET news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
-100.00%
24.99
Operating Revenue
0.00
0.00
0.00
-100.00%
24.99
Operating Expense
122.11
-4.31%
127.61
-3.74%
132.58
+35.92%
97.54
Research And Development
99.13
-0.20%
99.32
-6.34%
106.04
+48.84%
71.25
Selling General And Administration
22.99
-18.75%
28.29
+6.63%
26.53
+0.91%
26.30
General And Administrative Expense
22.99
-18.75%
28.29
+6.63%
26.53
+0.91%
26.30
Other Gand A
22.99
-18.75%
28.29
+6.63%
26.53
+0.91%
26.30
Total Expenses
122.11
-4.31%
127.61
-3.74%
132.58
+35.92%
97.54
Operating Income
-122.11
+4.31%
-127.61
+3.74%
-132.58
-82.73%
-72.55
Total Operating Income As Reported
-122.11
+4.31%
-127.61
+16.06%
-152.04
-109.56%
-72.55
EBITDA
-110.39
+0.24%
-110.65
+18.96%
-136.53
-103.37%
-67.14
Normalized EBITDA
-110.39
+0.24%
-110.65
+5.49%
-117.07
-74.38%
-67.14
Reconciled Depreciation
6.38
-1.35%
6.47
+6.07%
6.10
+136.82%
2.58
EBIT
-116.77
+0.30%
-117.12
+17.89%
-142.63
-104.61%
-69.71
Total Unusual Items
—
0.00
+100.00%
-19.46
0.00
Total Unusual Items Excluding Goodwill
—
0.00
+100.00%
-19.46
0.00
Special Income Charges
—
0.00
+100.00%
-19.46
0.00
Impairment Of Capital Assets
—
0.00
-100.00%
19.46
0.00
Net Income
-116.80
+0.27%
-117.12
+17.90%
-142.66
-104.41%
-69.79
Pretax Income
-116.80
+0.27%
-117.12
+17.90%
-142.66
-104.41%
-69.79
Net Non Operating Interest Income Expense
5.74
-46.40%
10.71
+7.61%
9.95
+170.46%
3.68
Interest Expense Non Operating
0.04
+800.00%
0.00
-84.00%
0.03
-68.75%
0.08
Net Interest Income
5.74
-46.40%
10.71
+7.61%
9.95
+170.46%
3.68
Interest Expense
0.04
+800.00%
0.00
-84.00%
0.03
-68.75%
0.08
Interest Income Non Operating
5.78
-46.08%
10.71
+7.38%
9.98
+165.37%
3.76
Interest Income
5.78
-46.08%
10.71
+7.38%
9.98
+165.37%
3.76
Other Income Expense
-0.43
-98.16%
-0.22
+98.92%
-20.04
-2080.09%
-0.92
Other Non Operating Income Expenses
-0.43
-98.16%
-0.22
+62.13%
-0.57
+37.65%
-0.92
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-116.80
+0.27%
-117.12
+17.90%
-142.66
-104.41%
-69.79
Net Income From Continuing Operation Net Minority Interest
-116.80
+0.27%
-117.12
+17.90%
-142.66
-104.41%
-69.79
Net Income From Continuing And Discontinued Operation
-116.80
+0.27%
-117.12
+17.90%
-142.66
-104.41%
-69.79
Net Income Continuous Operations
-116.80
+0.27%
-117.12
+17.90%
-142.66
-104.41%
-69.79
Normalized Income
-116.80
+0.27%
-117.12
+4.93%
-123.20
-76.52%
-69.79
Net Income Common Stockholders
-116.80
+0.27%
-117.12
+17.90%
-142.66
-104.41%
-69.79
Diluted EPS
-16.95
+20.35%
-21.28
+59.82%
-52.96
-94.71%
-27.20
Basic EPS
-16.95
+20.35%
-21.28
+59.82%
-52.96
-94.71%
-27.20
Basic Average Shares
6.89
+25.49%
5.49
+104.14%
2.69
+4.78%
2.57
Diluted Average Shares
6.89
+25.49%
5.49
+104.14%
2.69
+4.78%
2.57
Diluted NI Availto Com Stockholders
-116.80
+0.27%
-117.12
+17.90%
-142.66
-104.41%
-69.79
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
192.35
-12.65%
220.22
+6.23%
207.29
-37.31%
330.69
Current Assets
160.93
-10.66%
180.14
+11.01%
162.27
-37.84%
261.04
Cash Cash Equivalents And Short Term Investments
158.53
-10.08%
176.30
+10.39%
159.71
-38.01%
257.66
Cash And Cash Equivalents
38.92
-31.11%
56.49
-64.63%
159.71
-38.01%
257.66
Other Short Term Investments
119.61
-0.16%
119.81
0.00
—
Receivables
0.34
+252.58%
0.10
0.00
-100.00%
0.43
Accounts Receivable
—
—
—
0.00
Taxes Receivable
—
—
—
—
Accrued Interest Receivable
0.34
+252.58%
0.10
0.00
-100.00%
0.43
Prepaid Assets
1.73
-42.18%
3.00
+42.54%
2.10
-19.42%
2.61
Other Current Assets
0.32
-56.58%
0.74
+61.27%
0.46
+36.01%
0.34
Total Non Current Assets
31.43
-21.59%
40.08
-10.97%
45.02
-35.36%
69.65
Net PPE
28.48
-22.50%
36.75
-16.85%
44.20
-9.76%
48.98
Gross PPE
55.87
-3.79%
58.07
-1.66%
59.05
+2.28%
57.73
Accumulated Depreciation
-27.39
-28.49%
-21.32
-43.56%
-14.85
-69.62%
-8.75
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
—
—
—
—
Machinery Furniture Equipment
1.57
+1.29%
1.55
+0.19%
1.55
+118.76%
0.71
Construction In Progress
0.20
+0.00%
0.20
-25.28%
0.27
-97.15%
9.29
Other Properties
25.67
-8.59%
28.09
-8.18%
30.59
+10.14%
27.77
Leases
28.42
+0.69%
28.23
+5.95%
26.64
+33.49%
19.96
Goodwill And Other Intangible Assets
—
—
0.00
-100.00%
19.46
Goodwill
—
—
0.00
-100.00%
19.46
Investments And Advances
—
—
—
—
Other Non Current Assets
2.95
-11.50%
3.33
+305.23%
0.82
-32.12%
1.21
Total Liabilities Net Minority Interest
33.15
-1.38%
33.61
-9.46%
37.12
-3.21%
38.35
Current Liabilities
21.53
+11.03%
19.39
+0.54%
19.29
-2.13%
19.71
Payables And Accrued Expenses
12.71
+38.97%
9.15
-4.23%
9.55
-17.03%
11.51
Payables
4.74
-1.88%
4.83
+84.00%
2.62
-40.40%
4.40
Accounts Payable
4.74
-1.88%
4.83
+84.00%
2.62
-40.40%
4.40
Current Accrued Expenses
7.97
+84.67%
4.32
-37.66%
6.93
-2.55%
7.11
Pensionand Other Post Retirement Benefit Plans Current
5.63
-20.81%
7.11
+9.18%
6.51
+14.22%
5.70
Current Debt And Capital Lease Obligation
3.19
+1.72%
3.13
-2.76%
3.22
+29.25%
2.49
Current Capital Lease Obligation
3.19
+1.72%
3.13
-2.76%
3.22
+29.25%
2.49
Current Deferred Liabilities
—
—
—
0.00
Current Deferred Revenue
—
—
—
0.00
Total Non Current Liabilities Net Minority Interest
11.61
-18.31%
14.22
-20.27%
17.83
-4.36%
18.64
Long Term Debt And Capital Lease Obligation
11.55
-18.08%
14.10
-20.34%
17.70
-4.47%
18.53
Long Term Capital Lease Obligation
11.55
-18.08%
14.10
-20.34%
17.70
-4.47%
18.53
Non Current Deferred Liabilities
—
—
—
—
Non Current Deferred Taxes Liabilities
—
—
—
—
Other Non Current Liabilities
0.06
-46.55%
0.12
-10.77%
0.13
+14.04%
0.11
Stockholders Equity
159.21
-14.68%
186.61
+9.66%
170.18
-41.79%
292.34
Common Stock Equity
159.21
-14.68%
186.61
+9.66%
170.18
-41.79%
292.34
Capital Stock
0.01
+100.00%
0.01
+25.00%
0.00
+0.00%
0.00
Common Stock
0.01
+100.00%
0.01
+25.00%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
9.59
+85.77%
5.16
+90.82%
2.70
+0.73%
2.68
Ordinary Shares Number
9.59
+85.77%
5.16
+90.82%
2.70
+0.73%
2.68
Additional Paid In Capital
773.79
+13.05%
684.48
+24.24%
550.94
+3.86%
530.45
Retained Earnings
-614.70
-23.46%
-497.89
-30.76%
-380.77
-59.91%
-238.11
Gains Losses Not Affecting Retained Earnings
0.10
+537.50%
0.02
0.00
0.00
Other Equity Adjustments
0.10
+537.50%
0.02
—
—
Total Equity Gross Minority Interest
159.21
-14.68%
186.61
+9.66%
170.18
-41.79%
292.34
Total Capitalization
159.21
-14.68%
186.61
+9.66%
170.18
-41.79%
292.34
Working Capital
139.40
-13.28%
160.74
+12.42%
142.99
-40.75%
241.33
Invested Capital
159.21
-14.68%
186.61
+9.66%
170.18
-41.79%
292.34
Total Debt
14.74
-14.48%
17.23
-17.64%
20.92
-0.47%
21.02
Capital Lease Obligations
14.74
-14.48%
17.23
-17.64%
20.92
-0.47%
21.02
Net Tangible Assets
159.21
-14.68%
186.61
+9.66%
170.18
-37.64%
272.88
Tangible Book Value
159.21
-14.68%
186.61
+9.66%
170.18
-37.64%
272.88
Held To Maturity Securities
—
—
—
—
Investmentin Financial Assets
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-95.25
-3.10%
-92.38
+1.43%
-93.72
-109.35%
-44.77
Cash Flow From Continuing Operating Activities
-95.25
-3.10%
-92.38
+1.43%
-93.72
-109.35%
-44.77
Net Income From Continuing Operations
-116.80
+0.27%
-117.12
+17.90%
-142.66
-104.41%
-69.79
Depreciation Amortization Depletion
6.38
-1.35%
6.47
+6.07%
6.10
+136.82%
2.58
Depreciation And Amortization
6.38
-1.35%
6.47
+6.07%
6.10
+136.82%
2.58
Other Non Cash Items
3.43
+5.87%
3.24
+12.60%
2.87
+13.78%
2.53
Stock Based Compensation
14.27
-35.83%
22.23
+9.74%
20.26
+18.29%
17.13
Asset Impairment Charge
—
0.00
-100.00%
19.46
0.00
Operating Gains Losses
0.10
—
-0.00
-107.41%
0.05
Gain Loss On Sale Of PPE
0.10
0.00
+100.00%
-0.00
-107.41%
0.05
Change In Working Capital
1.47
+126.66%
-5.53
-2292.46%
0.25
-90.82%
2.74
Change In Receivables
—
—
—
0.18
Changes In Account Receivables
—
—
—
0.18
Change In Prepaid Assets
1.68
+232.26%
-1.27
-237.26%
0.93
-31.05%
1.34
Change In Payables And Accrued Expense
2.93
+420.20%
-0.92
+1.82%
-0.93
-112.37%
7.54
Change In Accrued Expense
1.90
+194.16%
-2.02
-369.60%
0.75
-87.14%
5.83
Change In Payable
1.03
-6.96%
1.11
+165.72%
-1.68
-198.42%
1.71
Change In Account Payable
1.03
-6.96%
1.11
+165.72%
-1.68
-198.42%
1.71
Change In Other Working Capital
—
—
—
-4.80
Change In Other Current Assets
0.31
-12.75%
0.35
-1.40%
0.36
-61.46%
0.93
Change In Other Current Liabilities
-3.45
+6.56%
-3.69
-3628.28%
-0.10
+95.63%
-2.26
Investing Cash Flow
2.39
+102.01%
-119.24
-2571.19%
-4.46
+73.40%
-16.78
Cash Flow From Continuing Investing Activities
2.39
+102.01%
-119.24
-2571.19%
-4.46
+73.40%
-16.78
Net PPE Purchase And Sale
-1.74
-55.46%
-1.12
+74.96%
-4.46
+73.40%
-16.78
Purchase Of PPE
-1.74
-55.46%
-1.12
+74.96%
-4.46
+73.40%
-16.78
Capital Expenditure
-1.74
-55.46%
-1.12
+74.96%
-4.46
+73.40%
-16.78
Net Investment Purchase And Sale
4.13
+103.50%
-118.12
0.00
0.00
Purchase Of Investment
-140.87
-9.10%
-129.12
0.00
—
Sale Of Investment
145.00
+1218.18%
11.00
0.00
0.00
Financing Cash Flow
75.25
-32.40%
111.31
+47063.98%
0.24
-99.43%
41.51
Cash Flow From Continuing Financing Activities
75.25
-32.40%
111.31
+47063.98%
0.24
-99.43%
41.51
Net Issuance Payments Of Debt
-0.15
0.00
—
—
Repayment Of Debt
-0.15
0.00
—
—
Long Term Debt Payments
-0.15
0.00
—
—
Net Long Term Debt Issuance
-0.15
0.00
—
—
Net Common Stock Issuance
75.17
-32.23%
110.92
0.00
-100.00%
43.36
Proceeds From Stock Option Exercised
0.33
-38.30%
0.53
+37.31%
0.39
-77.90%
1.75
Net Other Financing Charges
-0.10
+26.24%
-0.14
+6.00%
-0.15
+95.83%
-3.60
Changes In Cash
-17.61
+82.45%
-100.31
-2.42%
-97.94
-388.80%
-20.04
Beginning Cash Position
59.40
-62.81%
159.71
-38.01%
257.66
-7.22%
277.69
End Cash Position
41.79
-29.64%
59.40
-62.81%
159.71
-38.01%
257.66
Free Cash Flow
-96.98
-3.73%
-93.50
+4.77%
-98.18
-59.52%
-61.55
Income Tax Paid Supplemental Data
—
—
—
0.00
Amortization Of Securities
-4.09
-145.38%
-1.67
0.00
0.00
Common Stock Issuance
75.17
-32.23%
110.92
0.00
-100.00%
43.36
Issuance Of Capital Stock
75.17
-32.23%
110.92
0.00
-100.00%
43.36
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category